Heal Rapidly

About the offering

Why Should You Invest—and Why Now? Heal Rapidly represents an extraordinary opportunity in the healthcare market, with a path to significant returns. By capturing just 4% of the market share of its closest competitor, it is our projection we aim to return your investment within three years. With the company’s current valuation at $3.5 million, a $400,000 investment translates to an 11.43% equity stake. Thanks to a 50% margin on our product, we forecast $2.4 million in sales in the first two years, potentially yielding $1.2 million in net income. This would increase our company’s valuation to $6 million—a 5X return on net income. We expect sales to scale rapidly as the product gains market recognition and new claims are validated. We believe this funding round will be the final one needed to achieve our milestones. Please note that these numbers are projections and are not guaranteed. The Product: A Revolution in Wound Healing Heal Rapidly is a patent-pending liquid band-aid designed to transform wound care. This easy-to-use spray reduces pain, minimizes inflammation, and accelerates healing of cuts by 11-13%, based on promising results from controlled studies. We are seeking $400,000 in this final funding round to secure FDA approval as a liquid wound dressing and bring Heal Rapidly to market within six months. The Problem: Gaps in Current Wound Care Solutions Wound care has remained largely unchanged for decades. Most treatments offer minimal comfort, and if infection or debris is present, healing time increases significantly. Existing products are often messy, have unpleasant odors, and may cause pain or even mild toxicity. Furthermore, most lack reliable evidence of efficacy, leaving consumers frustrated and underserved. Our Solution: Heal Rapidly Heal Rapidly is a game-changing solution. This simple spray not only reduces pain but also creates an optimal moist environment for faster healing. By promoting a healthier, infection-free healing process, it accelerates recovery while providing comfort. Heal Rapidly is scientifically designed to reduce inflammation, protect against infection, and enhance healing speed, offering a unique and much-needed alternative to current options. Market Opportunity: Capturing a Growing Market Heal Rapidly enters a market dominated by products that fail to address the critical needs of faster healing and pain relief. Our closest competitor is a stabilized hypochlorous acid solution approved by the FDA as a topical wound dressing. While it sold 70,000 units on Amazon at $30 for a 3 oz spray in August 2023, it lacks evidence of accelerated healing or pain relief. Heal Rapidly outshines this product with proven efficacy and a competitive price of $20 for a 2 oz spray. Additionally, common alternatives such as silver compounds, antibiotic ointments like Neosporin, and debridement agents like iodine and peroxide do not accelerate healing or reduce pain. Heal Rapidly fills this gap with a product backed by science, positioned to disrupt a multi-million-dollar industry. Research Studies: Strong Scientific Validation 1: Wound Healing Mouse Studies: Two controlled mouse studies were conducted at Oregon State University to evaluate wound healing. The results demonstrated an 11-13% reduction in wound area (see below) in the treated group compared to the control group, with statistical significance (p<0.05). 2: Xenograft Mouse Study - Conducted at Epistem and Oregon State University, this study used human skin grafted onto mice to simulate inflammatory reactions. Results showed a significant decrease in inflammation and inflammatory markers in Heal Rapidly-treated skin compared to controls, validating its anti-inflammatory and healing properties. 3: Rabbit Skin Irritation Trial - Under GLP conditions, this study tested Heal Rapidly on 12 New Zealand White Rabbits. No irritation or adverse effects were observed, confirming the product’s safety for repeated dermal applications. 4: Human Skin Irritation Study - In a randomized, blinded, controlled study involving 41 healthy human volunteers, no signs of irritation were reported after using Heal Rapidly, reinforcing its safety profile. 5: Multi-center Study on Humans - A study with 172 human subjects assessed the safety of Heal Rapidly for treating recurrent cold sores. No skin irritation was observed, and the product was well tolerated by all participants. 6: Stability and Production Readiness - Heal Rapidly has successfully completed production and bottling procedures. FDA approval for use as a topical wound dressing is expected within six months, paving the way for market entry. Potential for Future Expansion of Claims Beyond its current applications, Heal Rapidly shows immense potential for expansion into additional therapeutic areas. Anecdotal evidence and early-stage trials suggest that Heal Rapidly may be effective in treating a variety of conditions, including: Burns, Cuts, and Abrasions: Accelerates healing and reduces pain from minor burns, cuts, and abrasions. Sunburns: Quickly alleviates pain by reducing inflammation and accelerating the healing process, providing fast relief and comfort. Insect Bites: Effective for bites from spiders, yellow jackets, wasps, mosquitoes, and other insects. Marine and Environmental Injuries: Provides relief from injuries caused by coral, and stinging jellyfish. Skin Infections: Demonstrated efficacy in treating infections such as MRSA (Methicillin-resistant Staphylococcus aureus). Mouth Sores: Alleviates pain from aphthous stomatitis (mouth ulcers). Veterinary Use: Shown to relieve skin irritation in pets, including cats and dogs. These promising uses position Heal Rapidly to expand its product claims, offering both short-term growth and long-term diversification potential. The Ask: Join Us in Transforming Wound Care Your investment in Heal Rapidly will enable us to complete the FDA approval process and bring this innovative product to market. With proven safety and efficacy, a clear path to growth, and the potential to revolutionize wound care, Heal Rapidly offers an exceptional opportunity for both financial returns and meaningful impact in healthcare. Competitive Landscape: A Unique Market Opportunity Heal Rapidly is poised to create a distinct and profitable segment within the wound care market. Currently, no product exists that accelerates wound healing safely and effectively, as proven in clinical studies. Consumers are increasingly looking for solutions that allow them to heal quickly and comfortably without fear of adverse reactions. Heal Rapidly addresses this gap by offering a clinically validated solution that accelerates healing, reduces pain, and provides protection against infection. We will position Heal Rapidly as the breakthrough treatment that the market has long awaited a product, that not only meets the needs of consumers but also offers a unique, science-backed solution that will transform wound care. Business Mechanics: A Clear Path to Profitability Our financial model is designed with one primary goal in mind: to repay your investment within three years and then distribute the majority of profits to our investors. Based on the current revenue model, the company is projected to reach a net value of $6 million within two years of sales. This valuation is grounded in the successful FDA approval of Heal Rapidly and two years of online sales, generating an estimated $2.4 million in gross revenue. With a 50% profit margin, the $2.4 million in sales will translate into $1.2 million in net income, which drives the company’s valuation to $6 million (a 5X multiple on net income) by year three. The projected five-year income model reflects a slight dip below 50% net profit due to initial ramp-up costs, but we anticipate rapid growth once the product is launched. The first year will involve no sales during the initial 9-month period while fundraising efforts and FDA approval are underway, followed by a strong sales ramp-up once Heal Rapidly enters the marketplace. Finances: Strong Financial Growth and Global Expansion Potential Heal Rapidly is currently patent-pending in the United States, with 20 years of patent protection, providing a solid foundation for long-term market dominance. We plan to file additional patents in other countries during the first year of operations to expand our global footprint. The pre-money valuation of the company is estimated at $3.5 million, based on the initial market for minor human trauma treatment in the United States. However, the financial potential extends far beyond this initial market. Heal Rapidly has promising applications for other common human conditions, such as: Burns, Insect Bites, Simple Diabetic Ulcers, Inflammation Additionally, Heal Rapidly can be used in veterinary care to treat conditions such as allergic itching and other skin ailments in animals. As consumer awareness and acceptance grow in these additional markets, Heal Rapidly’s valuation is expected to significantly increase, offering investors an opportunity for substantial returns as the product expands into new therapeutic areas. Testimonials Testimonial #1) I can't speak highly enough of Heal Rapidly!: I had a deep cut on my hand that got badly infected with lines going up my arm. I was fortunate enough to have a sample bottle of Heal Rapidly so I sprayed some on the infected cut. The next day I was happy to see the lines were gone and the wound was pink and healing. Heal Rapidly definitely saved me a Doctors visit! Then last summer I was unaware that I had a yellow jacket nest near my back door. When I went outside I was swarmed and stung 17 times! When I ran into my house to get away from the swarm I started feeling dizzy and the stings were swollen and bright red. I sprayed some Heal Rapidly on the stings and after a few minutes I no longer felt dizzy and it took away the pain, redness and swelling. Heal Rapidly is truly an amazing product! Thank you Dr Konowalchuk! Best Regards, Gail Lowry Testimonial #2) email from Carol Hepburn: Tom. This is day four of treatment with heal rapidly. Our friend, Simona cut her foot badly, took two different courses of two weeks, each antibiotics, and was still feeling pain and limping around on her foot when we met her. We introduced her to heal rapidly. I have pictures of the prior three days beginning the morning after she first applied it in the evening (first picture). (Second picture is 2 days post application and third picture is 4 days post application). I will send those to you too, she said the pain was gone by the next morning and she sends you a big thank you.

FAQ